Skip to main content
padlock icon - secure page this page is secure

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia

Buy Article:

$59.00 + tax (Refund Policy)

To assess long‐term treatment patterns and outcomes in patients with persistent or chronic immune thrombocytopenia (ITP), also considering the impact of the treatment with thrombopoietin receptor agonists (TPO‐RAs) prior to splenectomy.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: blood platelets; immune thrombocytopenia; splenectomy; thrombopoietin receptor agonists

Document Type: Research Article

Publication date: March 1, 2018

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more